Tessera Therapeutics
Blood & Organ Banks · United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.tesseratx.comRevenue
$7.8 MillionIndustry
About Tessera Therapeutics
Tessera Therapeutics is an early-stage life sciences company that is pioneering Gene Writing™, a novel biotechnology aimed at enabling scientists and doctors to treat diseases at their source by writing therapeutic messages into the genome. Their versatile technology platform allows for permanent alterations to the human genome, addressing major unmet medical needs with potentially curative therapies. The company is also developing non-viral delivery technologies to ensure genomic alterations are made precisely where needed. Tessera Therapeutics focuses on expanding the possibilities in genetic medicine to improve patient outcomes.Explore more
Tessera Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Tessera Therapeutics
Compare insights from companies similar to Tessera Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Tessera Therapeutics
$7.8M
201-500
Private
-
-
JM
Jeffrey MaranianSenior VP, Finance & Chief Accounting Officer
Tessera Therapeutics Tech Stack
A closer look at the technologies used by Tessera Therapeutics
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tessera Therapeutics
Sign Up For FreeTo access detailed company insights
Tessera Therapeutics is an early-stage life sciences company that is pioneering Gene Writing™, a novel biotechnology aimed at enabling scientists and doctors to treat diseases at their source by writing therapeutic messages into the genome. Their versatile technology platform allows for permanent alterations to the human genome, addressing major un... Read More
